| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 36 | 2025 | 822 | 4.800 |
Why?
|
| Probiotics | 22 | 2025 | 229 | 4.270 |
Why?
|
| Bacterial Proteins | 25 | 2025 | 924 | 3.480 |
Why?
|
| Bacillus subtilis | 13 | 2024 | 50 | 2.790 |
Why?
|
| Microbiota | 11 | 2025 | 441 | 2.620 |
Why?
|
| Genetic Engineering | 5 | 2018 | 165 | 2.180 |
Why?
|
| Ribosomal Proteins | 13 | 2024 | 76 | 2.090 |
Why?
|
| Gastrointestinal Tract | 6 | 2025 | 236 | 1.970 |
Why?
|
| GTP Phosphohydrolases | 10 | 2022 | 156 | 1.840 |
Why?
|
| Clostridium Infections | 10 | 2025 | 251 | 1.800 |
Why?
|
| Ribosomes | 9 | 2024 | 141 | 1.710 |
Why?
|
| Bioreactors | 5 | 2025 | 44 | 1.620 |
Why?
|
| Feces | 15 | 2025 | 783 | 1.520 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2025 | 173 | 1.410 |
Why?
|
| Ribosome Subunits, Large, Bacterial | 8 | 2024 | 8 | 1.300 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2020 | 74 | 1.260 |
Why?
|
| Genome, Bacterial | 8 | 2021 | 213 | 1.190 |
Why?
|
| Ribotyping | 3 | 2025 | 49 | 1.150 |
Why?
|
| Intestines | 14 | 2025 | 600 | 1.140 |
Why?
|
| Enteroendocrine Cells | 2 | 2025 | 21 | 1.090 |
Why?
|
| Culture Media | 6 | 2024 | 183 | 0.970 |
Why?
|
| Inflammation | 7 | 2025 | 1556 | 0.950 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2025 | 18 | 0.940 |
Why?
|
| Colitis | 2 | 2025 | 164 | 0.930 |
Why?
|
| Propane | 7 | 2020 | 28 | 0.930 |
Why?
|
| Glyceraldehyde | 7 | 2020 | 28 | 0.930 |
Why?
|
| Flagellin | 1 | 2025 | 21 | 0.930 |
Why?
|
| Biosensing Techniques | 2 | 2025 | 69 | 0.920 |
Why?
|
| Fungi | 1 | 2025 | 75 | 0.900 |
Why?
|
| Brain Death | 1 | 2025 | 75 | 0.880 |
Why?
|
| Bacteria | 8 | 2025 | 536 | 0.870 |
Why?
|
| Lactococcus lactis | 3 | 2013 | 6 | 0.870 |
Why?
|
| Hormones | 1 | 2025 | 197 | 0.870 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2015 | 93 | 0.850 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2024 | 403 | 0.800 |
Why?
|
| Animals | 49 | 2025 | 36189 | 0.770 |
Why?
|
| Dietary Sugars | 2 | 2020 | 16 | 0.750 |
Why?
|
| Bone Resorption | 3 | 2020 | 52 | 0.750 |
Why?
|
| Trehalose | 2 | 2019 | 21 | 0.740 |
Why?
|
| Enterococcus faecalis | 2 | 2020 | 50 | 0.730 |
Why?
|
| Tissue Donors | 1 | 2025 | 507 | 0.730 |
Why?
|
| Mice | 33 | 2025 | 18930 | 0.720 |
Why?
|
| Peptides | 3 | 2025 | 863 | 0.720 |
Why?
|
| Intestinal Mucosa | 11 | 2024 | 793 | 0.700 |
Why?
|
| Legislation, Drug | 1 | 2020 | 9 | 0.690 |
Why?
|
| Dysbiosis | 6 | 2024 | 145 | 0.690 |
Why?
|
| Organoids | 8 | 2024 | 301 | 0.690 |
Why?
|
| Microbiological Techniques | 1 | 2020 | 34 | 0.670 |
Why?
|
| Models, Biological | 4 | 2019 | 1530 | 0.660 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 18 | 0.660 |
Why?
|
| Metalloproteases | 1 | 2020 | 15 | 0.660 |
Why?
|
| Anti-Bacterial Agents | 11 | 2021 | 2575 | 0.650 |
Why?
|
| Incretins | 1 | 2020 | 24 | 0.640 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2019 | 21 | 0.640 |
Why?
|
| Fecal Microbiota Transplantation | 5 | 2024 | 106 | 0.610 |
Why?
|
| Colon | 6 | 2024 | 373 | 0.600 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 139 | 0.580 |
Why?
|
| Lactobacillaceae | 1 | 2017 | 1 | 0.560 |
Why?
|
| Bone and Bones | 2 | 2017 | 306 | 0.540 |
Why?
|
| Bone Remodeling | 2 | 2017 | 59 | 0.540 |
Why?
|
| Lactobacillus | 5 | 2014 | 47 | 0.540 |
Why?
|
| Humans | 62 | 2025 | 133147 | 0.540 |
Why?
|
| Disease Models, Animal | 12 | 2025 | 4755 | 0.530 |
Why?
|
| Metagenome | 4 | 2025 | 157 | 0.500 |
Why?
|
| Microbial Consortia | 1 | 2016 | 7 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4823 | 0.480 |
Why?
|
| DNA, Single-Stranded | 2 | 2012 | 76 | 0.470 |
Why?
|
| Bile Acids and Salts | 3 | 2020 | 257 | 0.460 |
Why?
|
| Genomics | 3 | 2020 | 1672 | 0.460 |
Why?
|
| Osteoporosis | 4 | 2020 | 140 | 0.460 |
Why?
|
| Bone Density | 5 | 2020 | 374 | 0.450 |
Why?
|
| Biomedical Research | 1 | 2020 | 551 | 0.450 |
Why?
|
| Sjogren's Syndrome | 3 | 2021 | 98 | 0.440 |
Why?
|
| Models, Molecular | 10 | 2024 | 1146 | 0.440 |
Why?
|
| Ovariectomy | 1 | 2014 | 189 | 0.430 |
Why?
|
| Bifidobacterium | 3 | 2025 | 70 | 0.390 |
Why?
|
| Cell Line | 5 | 2020 | 2855 | 0.390 |
Why?
|
| Microbial Interactions | 1 | 2012 | 17 | 0.380 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2008 | 1067 | 0.370 |
Why?
|
| Gastrointestinal Hormones | 2 | 2023 | 21 | 0.370 |
Why?
|
| Homologous Recombination | 1 | 2012 | 100 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 684 | 0.360 |
Why?
|
| Jejunum | 3 | 2020 | 130 | 0.360 |
Why?
|
| DNA, Bacterial | 2 | 2012 | 490 | 0.350 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2010 | 8 | 0.350 |
Why?
|
| Fusobacterium nucleatum | 2 | 2021 | 25 | 0.340 |
Why?
|
| RNA, Ribosomal, 23S | 2 | 2024 | 22 | 0.340 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 452 | 0.340 |
Why?
|
| Glycerol | 3 | 2017 | 99 | 0.340 |
Why?
|
| Escherichia coli Infections | 2 | 2021 | 195 | 0.330 |
Why?
|
| Methyltransferases | 1 | 2011 | 83 | 0.330 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 61 | 0.320 |
Why?
|
| Phylogeny | 4 | 2025 | 777 | 0.320 |
Why?
|
| Immunologic Factors | 1 | 2011 | 186 | 0.310 |
Why?
|
| Rotavirus Infections | 2 | 2024 | 359 | 0.310 |
Why?
|
| Osteoblasts | 4 | 2020 | 164 | 0.310 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 311 | 0.310 |
Why?
|
| Environment | 2 | 2020 | 154 | 0.310 |
Why?
|
| Rotavirus | 2 | 2024 | 505 | 0.310 |
Why?
|
| Germ-Free Life | 4 | 2020 | 65 | 0.300 |
Why?
|
| Phenotype | 5 | 2025 | 4575 | 0.300 |
Why?
|
| Bread | 1 | 2008 | 5 | 0.300 |
Why?
|
| Conjunctiva | 2 | 2021 | 187 | 0.300 |
Why?
|
| Calcium Signaling | 2 | 2020 | 257 | 0.290 |
Why?
|
| Escherichia coli | 4 | 2023 | 1031 | 0.290 |
Why?
|
| Epithelial Cells | 5 | 2021 | 932 | 0.290 |
Why?
|
| Homeostasis | 2 | 2025 | 748 | 0.280 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2024 | 82 | 0.280 |
Why?
|
| RNA, Ribosomal | 3 | 2022 | 66 | 0.280 |
Why?
|
| Enteritis | 2 | 2020 | 37 | 0.280 |
Why?
|
| Escherichia coli Proteins | 3 | 2019 | 316 | 0.280 |
Why?
|
| Flagella | 2 | 2025 | 29 | 0.280 |
Why?
|
| Fermentation | 5 | 2017 | 71 | 0.270 |
Why?
|
| Lacrimal Apparatus | 2 | 2019 | 121 | 0.270 |
Why?
|
| Intestine, Small | 2 | 2021 | 312 | 0.270 |
Why?
|
| Adhesins, Bacterial | 2 | 2020 | 75 | 0.270 |
Why?
|
| 5' Flanking Region | 1 | 2007 | 10 | 0.270 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 275 | 0.270 |
Why?
|
| Ribonucleases | 1 | 2007 | 51 | 0.260 |
Why?
|
| Biodiversity | 3 | 2015 | 89 | 0.260 |
Why?
|
| Virulence | 2 | 2025 | 278 | 0.260 |
Why?
|
| Biomarkers | 3 | 2025 | 3411 | 0.260 |
Why?
|
| Bacteroides | 2 | 2024 | 37 | 0.260 |
Why?
|
| Symbiosis | 3 | 2021 | 102 | 0.260 |
Why?
|
| Calcium | 3 | 2020 | 1104 | 0.250 |
Why?
|
| Oxidative Stress | 2 | 2020 | 868 | 0.250 |
Why?
|
| Prebiotics | 2 | 2017 | 29 | 0.250 |
Why?
|
| Systems Biology | 3 | 2022 | 63 | 0.250 |
Why?
|
| Arthritis, Experimental | 1 | 2025 | 22 | 0.240 |
Why?
|
| Thiouracil | 1 | 2025 | 2 | 0.240 |
Why?
|
| Drug Resistance, Fungal | 1 | 2025 | 30 | 0.240 |
Why?
|
| RNA, Bacterial | 1 | 2025 | 56 | 0.230 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 707 | 0.230 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 202 | 0.230 |
Why?
|
| Phage Therapy | 1 | 2025 | 39 | 0.220 |
Why?
|
| G-Quadruplexes | 1 | 2024 | 12 | 0.220 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2016 | 73 | 0.220 |
Why?
|
| Candida | 1 | 2025 | 84 | 0.220 |
Why?
|
| Cross Infection | 2 | 2022 | 344 | 0.220 |
Why?
|
| Transcriptome | 2 | 2021 | 1135 | 0.220 |
Why?
|
| Carbon | 1 | 2025 | 98 | 0.220 |
Why?
|
| Binding Sites | 5 | 2024 | 1378 | 0.220 |
Why?
|
| Aptamers, Nucleotide | 1 | 2024 | 36 | 0.220 |
Why?
|
| Cornea | 2 | 2019 | 595 | 0.220 |
Why?
|
| Female | 20 | 2025 | 71382 | 0.220 |
Why?
|
| Cryoelectron Microscopy | 4 | 2019 | 246 | 0.210 |
Why?
|
| Rotavirus Vaccines | 1 | 2024 | 73 | 0.210 |
Why?
|
| Coculture Techniques | 1 | 2024 | 245 | 0.210 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 18 | 0.210 |
Why?
|
| Indoles | 2 | 2021 | 202 | 0.210 |
Why?
|
| Hydrolysis | 4 | 2019 | 161 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2020 | 485 | 0.200 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 293 | 0.200 |
Why?
|
| Serotonin | 2 | 2023 | 222 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2025 | 295 | 0.200 |
Why?
|
| Fluorescent Dyes | 1 | 2024 | 268 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2025 | 270 | 0.200 |
Why?
|
| Regulon | 1 | 2002 | 11 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 1714 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 4 | 2024 | 1084 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2025 | 306 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2025 | 182 | 0.200 |
Why?
|
| Graft vs Host Disease | 2 | 2024 | 621 | 0.190 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.190 |
Why?
|
| Bacterial Toxins | 2 | 2020 | 177 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2025 | 1757 | 0.190 |
Why?
|
| Male | 19 | 2025 | 65472 | 0.190 |
Why?
|
| Radiation Protection | 1 | 2022 | 57 | 0.190 |
Why?
|
| Gene Expression Regulation | 4 | 2025 | 2650 | 0.190 |
Why?
|
| Butyrates | 1 | 2022 | 42 | 0.190 |
Why?
|
| Mutation | 5 | 2025 | 6340 | 0.190 |
Why?
|
| Gene Ontology | 1 | 2021 | 55 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2022 | 49 | 0.180 |
Why?
|
| Crowdsourcing | 1 | 2021 | 13 | 0.180 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 1914 | 0.170 |
Why?
|
| Virus Replication | 1 | 2024 | 635 | 0.170 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 163 | 0.170 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 584 | 0.170 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 46 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2020 | 306 | 0.170 |
Why?
|
| Adenosine Diphosphate | 1 | 2020 | 55 | 0.170 |
Why?
|
| Drug Industry | 1 | 2020 | 49 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 578 | 0.170 |
Why?
|
| Computational Biology | 4 | 2021 | 887 | 0.170 |
Why?
|
| Protein Binding | 6 | 2019 | 1850 | 0.170 |
Why?
|
| Bacterial Adhesion | 3 | 2020 | 106 | 0.170 |
Why?
|
| Macrolides | 1 | 2020 | 31 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 606 | 0.170 |
Why?
|
| Norovirus | 1 | 2024 | 349 | 0.170 |
Why?
|
| Alanine | 1 | 2021 | 184 | 0.170 |
Why?
|
| Polyphenols | 1 | 2020 | 24 | 0.170 |
Why?
|
| Sucrose | 1 | 2020 | 43 | 0.170 |
Why?
|
| Disease Resistance | 1 | 2020 | 28 | 0.170 |
Why?
|
| Clindamycin | 2 | 2020 | 42 | 0.160 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 59 | 0.160 |
Why?
|
| Sweetening Agents | 1 | 2020 | 37 | 0.160 |
Why?
|
| Intracellular Space | 1 | 2020 | 51 | 0.160 |
Why?
|
| Proteomics | 1 | 2024 | 602 | 0.160 |
Why?
|
| Ribosome Subunits, Small, Bacterial | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ribosome Subunits, Small | 1 | 2019 | 3 | 0.160 |
Why?
|
| Drug Design | 1 | 2021 | 168 | 0.160 |
Why?
|
| Trehalase | 1 | 2019 | 2 | 0.160 |
Why?
|
| Stem Cells | 1 | 2024 | 747 | 0.150 |
Why?
|
| Secretory Pathway | 1 | 2019 | 13 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 767 | 0.150 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 63 | 0.150 |
Why?
|
| Mangifera | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hydrolyzable Tannins | 1 | 2018 | 4 | 0.150 |
Why?
|
| Social Behavior Disorders | 1 | 2018 | 12 | 0.150 |
Why?
|
| Space Flight | 1 | 2022 | 170 | 0.150 |
Why?
|
| Microbial Viability | 2 | 2010 | 43 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2017 | 787 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 187 | 0.150 |
Why?
|
| Lactobacillus johnsonii | 1 | 2018 | 2 | 0.150 |
Why?
|
| Virulence Factors | 1 | 2020 | 187 | 0.140 |
Why?
|
| Adult | 7 | 2025 | 31608 | 0.140 |
Why?
|
| Dacryocystitis | 1 | 2018 | 21 | 0.140 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 285 | 0.140 |
Why?
|
| Linoleic Acid | 1 | 2018 | 19 | 0.140 |
Why?
|
| Asia | 1 | 2018 | 125 | 0.140 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 54 | 0.140 |
Why?
|
| Keratoconjunctivitis | 1 | 2018 | 19 | 0.140 |
Why?
|
| Cholestasis | 1 | 2020 | 157 | 0.140 |
Why?
|
| Soybean Oil | 1 | 2018 | 71 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 316 | 0.140 |
Why?
|
| Cluster Analysis | 2 | 2015 | 436 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 527 | 0.140 |
Why?
|
| Tetrathionic Acid | 1 | 2017 | 2 | 0.140 |
Why?
|
| Europe | 1 | 2018 | 373 | 0.140 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Thiosulfates | 1 | 2017 | 7 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 1325 | 0.130 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 638 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 386 | 0.130 |
Why?
|
| Middle Aged | 5 | 2025 | 28911 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 269 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 403 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 267 | 0.130 |
Why?
|
| Anaerobiosis | 1 | 2016 | 15 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 1152 | 0.120 |
Why?
|
| Genotype | 2 | 2020 | 2717 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2024 | 2026 | 0.120 |
Why?
|
| Premature Birth | 1 | 2020 | 417 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2014 | 814 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1849 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 622 | 0.110 |
Why?
|
| Suppression, Genetic | 1 | 2014 | 43 | 0.110 |
Why?
|
| Bacteroides thetaiotaomicron | 2 | 2024 | 9 | 0.110 |
Why?
|
| HT29 Cells | 3 | 2021 | 45 | 0.110 |
Why?
|
| Recombinases | 1 | 2014 | 26 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2014 | 19 | 0.110 |
Why?
|
| Femur | 1 | 2014 | 75 | 0.110 |
Why?
|
| Ribosome Subunits | 2 | 2017 | 3 | 0.110 |
Why?
|
| Propionates | 1 | 2014 | 33 | 0.110 |
Why?
|
| Hydro-Lyases | 2 | 2014 | 9 | 0.110 |
Why?
|
| RANK Ligand | 1 | 2014 | 54 | 0.110 |
Why?
|
| Vagina | 2 | 2023 | 205 | 0.110 |
Why?
|
| Endonucleases | 1 | 2014 | 56 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2014 | 73 | 0.110 |
Why?
|
| Menopause | 1 | 2014 | 90 | 0.110 |
Why?
|
| Vancomycin | 2 | 2017 | 236 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2015 | 225 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 157 | 0.110 |
Why?
|
| Mucus | 1 | 2014 | 38 | 0.110 |
Why?
|
| Spine | 1 | 2014 | 147 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2014 | 24 | 0.110 |
Why?
|
| Equipment Design | 1 | 2016 | 604 | 0.110 |
Why?
|
| Malnutrition | 1 | 2016 | 221 | 0.100 |
Why?
|
| Epidemics | 1 | 2014 | 59 | 0.100 |
Why?
|
| Mutagenesis | 3 | 2013 | 356 | 0.100 |
Why?
|
| Arrestins | 1 | 2013 | 29 | 0.100 |
Why?
|
| Organ Size | 1 | 2014 | 463 | 0.100 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 813 | 0.100 |
Why?
|
| Guanine Nucleotides | 1 | 2013 | 14 | 0.100 |
Why?
|
| Siphoviridae | 1 | 2013 | 3 | 0.100 |
Why?
|
| Autism Spectrum Disorder | 1 | 2018 | 430 | 0.100 |
Why?
|
| HEK293 Cells | 3 | 2021 | 825 | 0.100 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2012 | 1 | 0.100 |
Why?
|
| Operon | 1 | 2012 | 54 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 33 | 0.100 |
Why?
|
| Salmonella typhimurium | 1 | 2012 | 43 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 329 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1710 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2002 | 2719 | 0.090 |
Why?
|
| Guanosine Diphosphate | 1 | 2012 | 12 | 0.090 |
Why?
|
| Chromosomes, Bacterial | 1 | 2012 | 65 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2013 | 299 | 0.090 |
Why?
|
| Guanosine Triphosphate | 1 | 2012 | 45 | 0.090 |
Why?
|
| DNA Mismatch Repair | 1 | 2012 | 53 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1163 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 670 | 0.090 |
Why?
|
| Histamine | 1 | 2012 | 49 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 2 | 2024 | 202 | 0.090 |
Why?
|
| Recurrence | 1 | 2015 | 1469 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 415 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2013 | 334 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 149 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 172 | 0.090 |
Why?
|
| Coinfection | 1 | 2013 | 182 | 0.090 |
Why?
|
| Kidney Cortex Necrosis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cecum | 1 | 2010 | 28 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 139 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 1770 | 0.090 |
Why?
|
| Aged | 3 | 2025 | 21446 | 0.080 |
Why?
|
| Mucin-2 | 2 | 2020 | 42 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3960 | 0.080 |
Why?
|
| Vertebrates | 1 | 2010 | 39 | 0.080 |
Why?
|
| Fatty Acids, Volatile | 2 | 2022 | 47 | 0.080 |
Why?
|
| Protein Conformation | 3 | 2019 | 873 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2021 | 4915 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 509 | 0.080 |
Why?
|
| Acrolein | 1 | 2010 | 11 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2020 | 3978 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2018 | 1582 | 0.080 |
Why?
|
| RNA | 2 | 2024 | 606 | 0.080 |
Why?
|
| Ligands | 2 | 2024 | 571 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2010 | 254 | 0.080 |
Why?
|
| Monocytes | 1 | 2011 | 346 | 0.070 |
Why?
|
| Cytokines | 3 | 2021 | 1377 | 0.070 |
Why?
|
| Sepsis | 1 | 2013 | 522 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 3041 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2784 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2014 | 806 | 0.070 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2007 | 26 | 0.070 |
Why?
|
| Esterases | 1 | 2007 | 13 | 0.070 |
Why?
|
| Rats | 2 | 2025 | 3850 | 0.070 |
Why?
|
| Cell Wall | 1 | 2007 | 40 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 874 | 0.070 |
Why?
|
| Obesity | 1 | 2018 | 2436 | 0.060 |
Why?
|
| Weight Loss | 1 | 2010 | 516 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2024 | 393 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2020 | 415 | 0.060 |
Why?
|
| Swine | 2 | 2020 | 1200 | 0.060 |
Why?
|
| Biological Assay | 2 | 2020 | 111 | 0.060 |
Why?
|
| Neoplasms | 1 | 2021 | 2984 | 0.060 |
Why?
|
| Genes, Bacterial | 1 | 2006 | 218 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2018 | 536 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 304 | 0.060 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2025 | 5 | 0.060 |
Why?
|
| Pentosyltransferases | 1 | 2025 | 21 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2018 | 384 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2010 | 871 | 0.060 |
Why?
|
| G2 Phase | 1 | 2004 | 43 | 0.060 |
Why?
|
| Bacteria, Anaerobic | 1 | 2024 | 10 | 0.060 |
Why?
|
| Benzothiazoles | 1 | 2024 | 31 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 3223 | 0.060 |
Why?
|
| Biotin | 1 | 2024 | 48 | 0.060 |
Why?
|
| Virus Cultivation | 1 | 2024 | 76 | 0.060 |
Why?
|
| Secretin | 1 | 2023 | 16 | 0.050 |
Why?
|
| Bacteriophages | 1 | 2025 | 93 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 130 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 2144 | 0.050 |
Why?
|
| Quinolines | 1 | 2024 | 115 | 0.050 |
Why?
|
| Oxytocin | 1 | 2023 | 74 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2025 | 718 | 0.050 |
Why?
|
| Imidazoles | 1 | 2004 | 218 | 0.050 |
Why?
|
| Kv1.3 Potassium Channel | 1 | 2023 | 37 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 367 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2023 | 103 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2004 | 340 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 677 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Potassium Channel Blockers | 1 | 2023 | 87 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 94 | 0.050 |
Why?
|
| Infant | 3 | 2025 | 13235 | 0.050 |
Why?
|
| Child Development | 1 | 2025 | 286 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1303 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 228 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2025 | 14862 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 40 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2008 | 2876 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 314 | 0.050 |
Why?
|
| Gastroenteritis | 1 | 2024 | 366 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 79 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 93 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 72 | 0.040 |
Why?
|
| Acids | 1 | 2021 | 31 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2521 | 0.040 |
Why?
|
| DNA Damage | 1 | 2004 | 517 | 0.040 |
Why?
|
| Caliciviridae Infections | 1 | 2024 | 360 | 0.040 |
Why?
|
| Base Sequence | 2 | 2019 | 3153 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 24 | 0.040 |
Why?
|
| Enterochromaffin Cells | 1 | 2020 | 11 | 0.040 |
Why?
|
| Biopsy | 1 | 2024 | 1201 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 282 | 0.040 |
Why?
|
| Receptors, Serotonin | 1 | 2020 | 43 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2020 | 49 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2020 | 74 | 0.040 |
Why?
|
| Clostridium | 1 | 2020 | 17 | 0.040 |
Why?
|
| Tears | 1 | 2022 | 176 | 0.040 |
Why?
|
| Actinobacteria | 1 | 2020 | 13 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 111 | 0.040 |
Why?
|
| Viruses | 1 | 2021 | 128 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 241 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 238 | 0.040 |
Why?
|
| Anisotropy | 1 | 2020 | 126 | 0.040 |
Why?
|
| ADP Ribose Transferases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cancellous Bone | 1 | 2020 | 8 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2020 | 122 | 0.040 |
Why?
|
| Acetates | 1 | 2020 | 80 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 312 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 319 | 0.040 |
Why?
|
| Time Factors | 3 | 2020 | 6541 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cell Shape | 1 | 2020 | 70 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 113 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 145 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 360 | 0.040 |
Why?
|
| Sp7 Transcription Factor | 1 | 2019 | 4 | 0.040 |
Why?
|
| Enterotoxins | 1 | 2020 | 82 | 0.040 |
Why?
|
| Biofilms | 1 | 2020 | 99 | 0.040 |
Why?
|
| B7-2 Antigen | 1 | 2019 | 16 | 0.040 |
Why?
|
| Mesentery | 1 | 2019 | 27 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 607 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 16 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 358 | 0.040 |
Why?
|
| Firmicutes | 1 | 2019 | 22 | 0.040 |
Why?
|
| Picrotoxin | 1 | 2018 | 14 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 504 | 0.040 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 34 | 0.040 |
Why?
|
| Benzoxazines | 1 | 2018 | 22 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 21 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 1019 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 291 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 54 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2018 | 77 | 0.040 |
Why?
|
| Parenteral Nutrition | 1 | 2020 | 199 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 283 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 477 | 0.040 |
Why?
|
| Phenols | 1 | 2018 | 56 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 482 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 372 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 188 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2020 | 839 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 835 | 0.040 |
Why?
|
| Permeability | 1 | 2018 | 131 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2018 | 168 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 1205 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 131 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2018 | 122 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 498 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8627 | 0.030 |
Why?
|
| Smell | 1 | 2018 | 131 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 522 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 395 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2017 | 17 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2017 | 6 | 0.030 |
Why?
|
| Shewanella | 1 | 2017 | 10 | 0.030 |
Why?
|
| Goblet Cells | 1 | 2018 | 106 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2018 | 168 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2020 | 399 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 233 | 0.030 |
Why?
|
| Piperidines | 1 | 2018 | 241 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 289 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 656 | 0.030 |
Why?
|
| Glucose | 1 | 2021 | 915 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 152 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 179 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 1090 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 256 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2024 | 1193 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 174 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 432 | 0.030 |
Why?
|
| Michigan | 1 | 2015 | 52 | 0.030 |
Why?
|
| Dry Eye Syndromes | 1 | 2019 | 284 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2017 | 640 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 95 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 521 | 0.030 |
Why?
|
| Public Health Surveillance | 1 | 2015 | 45 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2022 | 1594 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3131 | 0.030 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2014 | 6 | 0.030 |
Why?
|
| Metabolic Flux Analysis | 1 | 2014 | 12 | 0.030 |
Why?
|
| Metabolic Engineering | 1 | 2014 | 6 | 0.030 |
Why?
|
| Biotransformation | 1 | 2014 | 56 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1323 | 0.030 |
Why?
|
| Aminoacyltransferases | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2014 | 90 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2014 | 96 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 298 | 0.030 |
Why?
|
| beta-Arrestin 2 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 471 | 0.030 |
Why?
|
| beta-Arrestins | 1 | 2013 | 33 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2014 | 118 | 0.030 |
Why?
|
| Estrogens | 1 | 2016 | 523 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2013 | 77 | 0.030 |
Why?
|
| Adsorption | 1 | 2013 | 37 | 0.030 |
Why?
|
| Viral Tail Proteins | 1 | 2013 | 6 | 0.030 |
Why?
|
| Peptidoglycan | 1 | 2013 | 22 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 85 | 0.020 |
Why?
|
| Histidine Decarboxylase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Virion | 1 | 2013 | 151 | 0.020 |
Why?
|
| Receptors, Histamine H2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2854 | 0.020 |
Why?
|
| Histidine | 1 | 2012 | 75 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 529 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 456 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1608 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3794 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1136 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 884 | 0.020 |
Why?
|
| DNA Probes | 1 | 2008 | 124 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3406 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 457 | 0.020 |
Why?
|
| Maleimides | 1 | 2004 | 11 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 841 | 0.010 |
Why?
|
| Protein Kinase C beta | 1 | 2004 | 21 | 0.010 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2004 | 30 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 89 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2004 | 64 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 66 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 90 | 0.010 |
Why?
|
| Nitrogen | 1 | 2004 | 148 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1830 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1433 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 148 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2004 | 180 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 143 | 0.010 |
Why?
|
| Glutamine | 1 | 2004 | 218 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 9917 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 20528 | 0.010 |
Why?
|
| Child | 1 | 2015 | 25828 | 0.010 |
Why?
|